News
6don MSNOpinion
System that prioritizes opioids over non-addictive alternatives needs fixing, says ophthalmologist and Kansas senator.
The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...
2d
TheHyperHive on MSNIs This Non-Opioid Painkiller the End of the Opioid Crisis?How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...
The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...
Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...
On 30 January 2025, the US Food and Drug Administration (FDA) approved the non-opioid medication suzetrigine (JOURNAVX), which was developed by Vertex Pharmaceuticals for moderate to severe acute ...
Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my ...
More than one in three adults in the UK suffers from chronic pain — just under 28 million people, according to the National Institute for Health and Care Excellence (Nice). But until now, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results